FNB | ||
|---|---|---|
OUTLOOK RATING 1..100 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 30 | |
SMR RATING 1..100 | 11 | |
PRICE GROWTH RATING 1..100 | 48 | |
P/E GROWTH RATING 1..100 | 54 | |
SEASONALITY SCORE 1..100 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DON | FNB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | N/A |
| Stochastic ODDS (%) | 1 day ago 86% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 59% |
| MACD ODDS (%) | 1 day ago 80% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 58% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 52% |
| Advances ODDS (%) | 1 day ago 82% | 1 day ago 55% |
| Declines ODDS (%) | 8 days ago 78% | 16 days ago 59% |
| BollingerBands ODDS (%) | 1 day ago 85% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 58% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AAAVX | 13.30 | 0.21 | +1.60% |
| DWS RREEF Real Assets R6 | |||
| KSCYX | 175.77 | -0.08 | -0.05% |
| Kinetics Small Cap Opportunities Inst | |||
| RYOAX | 59.77 | -0.08 | -0.13% |
| Rydex Biotechnology H | |||
| CNPFX | 70.01 | -0.88 | -1.24% |
| American Funds New Perspective 529F | |||
| UGLSX | 58.79 | -1.50 | -2.49% |
| JHancock U.S. Global Leaders Growth R6 | |||
A.I.dvisor indicates that over the last year, DON has been closely correlated with GGG. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if DON jumps, then GGG could also see price increases.
A.I.dvisor indicates that over the last year, FNB has been closely correlated with WTFC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if FNB jumps, then WTFC could also see price increases.